CTCF, a transcriptional regulator that acts on enhancers, promoters, and gene bodies (59), together with other TFs in the lower left quadrant, displays decreased binding activity in both PiD and AD compared to their controls. This evidence concerns the gene CTCF and pelvic inflammatory disease.